Idiopathic giant-cell myocarditis
||This article includes a list of references, but its sources remain unclear because it has insufficient inline citations. (March 2015) (Learn how and when to remove this template message)|
|Idiopathic giant-cell myocarditis also known as Fiedler's myocarditis|
|Classification and external resources|
Idiopathic giant-cell myocarditis (IGCM) is a cardiovascular disease.
The condition is rare; however, it is often fatal and there is no proven cure because of the unknown nature of the disorder.
IGCM frequently leads to death with a high rate of about 70% in first year. A patient with IGCM typically presents with symptoms of heart failure although some may present initially with ventricular arrhythmia or heart block. Median age from the time the disease is diagnosed to the time of death is approximately 6 months. 90% of patients are either deceased by the end of 1 year or have received a heart transplant. Diagnosis is made by endomyocardial biopsy during heart catheterization. Biopsy shows multinucleated giant cells and thus the name. There is no treatment except for heart transplantation. The transplanted heart has a high chance of disease recurrence. Compared to lymphocytic (presumed viral) myocarditis, giant cell myocarditis is much more severe with much more rapid progression.
It is suggested to be caused by T-lymphocytes.
- Cooper LT, Berry GJ, Shabetai R (June 1997). "Idiopathic giant-cell myocarditis--natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators". N. Engl. J. Med. 336 (26): 1860–6. PMID 9197214. doi:10.1056/NEJM199706263362603.
|This article about a medical condition affecting the circulatory system is a stub. You can help Wikipedia by expanding it.|